Denali Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
70%
€23.00
Target price
30.05.27
€31.00
Performance (%)
-4.35%
End price
14.12.24
€22.00
Summary
This prediction ended on 14.12.24 with a price of €22.00. With a performance of -4.35%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Denali Therapeutics Inc. | 6.832% | 6.832% | 35.595% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % |
According to BiotechBee what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year